Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 18/20 | 0.80 |
| ▸ | CCND1 | P24385 | 16/20 | 0.80 |
| ▸ | CDK6 | Q00534 | 12/20 | 0.80 |
| ▸ | CCND3 | P30281 | 4/20 | 0.80 |
| ▸ | CDK2 | P24941 | 3/20 | 0.80 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.80 |
| ▸ | GAK | O14976 | 1/20 | 0.80 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.80 |
| ▸ | FECH | P22830 | 1/20 | 0.80 |
| ▸ | CDK9 | P50750 | 1/20 | 0.80 |
| ▸ | CDK16 | Q00536 | 1/20 | 0.80 |
| ▸ | MAP3K1 | Q13233 | 1/20 | 0.80 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.80 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.80 |
| ▸ | Q6ZSR9 | Q6ZSR9 | 1/20 | 0.80 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.80 |
| ▸ | SIK2 | Q9H0K1 | 1/20 | 0.80 |
| ▸ | CDK1 | P06493 | 1/20 | 0.77 |
| ▸ | CCND2 | P30279 | 3/20 | 0.73 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31121782 | 1.00 | CDK4 (0.80) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL303542 | 1.00 | CDK4 (0.80) | CDK4CCND1CDK6CCND3CDK2 | |
| Dimethylamine SCHEMBL28726027 | 0.92 | CDK4 (0.80) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL23837859 | 0.91 | CDK4 (0.83) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL29507453 | 0.91 | CDK4 (0.81) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL2685016 | 0.91 | CDK4 (0.81) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL2362403 | 0.90 | CDK4 (0.76) | CDK4CCND1CDK6CCND3CDK2 | |
| SCHEMBL20980374 | 0.90 | CDK4 (0.68) | CDK4CCND1CDK6CCND3CDK2 | |
| Ribociclib SCHEMBL302310 | 0.89 | CDK4 (1.00) | CDK4CCND1CDK6CCND3CDK2 | |
| Ribociclib SCHEMBL29384231 | 0.89 | CDK4 (1.00) | CDK4CCND1CDK6CCND3CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126244-A1 | COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR TREATMENT | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | claimed |
| CN-114245753-A | Combination of an anti-HER 2 antibody and a CDK inhibitor for tumor therapy | 江苏康宁杰瑞生物制药有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-119119054-A | Preparation method of N-demethyl rebamactinib | 天津法莫西医药科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-4126244-A1 | COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR TREATMENT | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | disclosed |
| CN-114245753-A | Combination of an anti-HER 2 antibody and a CDK inhibitor for tumor therapy | 江苏康宁杰瑞生物制药有限公司 | 2022-03-25 | — | — | CN | disclosed |